Substituted 3-Cyclobutene-1,2-diones
2541
CH3), 7.13 (d, 2H, J ¼ 8.2 Hz, ArH), 7.50–7.58 (m, 5H, Ph), 8.42 (d, 2H,
J ¼ 8.2 Hz, ArH), 10.12 (s, 1H, NH).
3-Cyclohexylamino-4-(4-methoxy-phenyl)-cyclobut-3-ene-
1,2-dione (19n)
This compound was obtained in 69% yield, mp 185–1878C (2-propanol).
LC MS m/z 285 (M þ 1); 1H NMR (500 MHz, DMSO-d6): 0.95–1.11
(m, 2H, CH2), 1.32–1.44 (m, 8H, 4CH2), 3.96 (s, 3H, CH3), 3.59–3.62
(m, 1H, NCH), 7.13 (d, 2H, J ¼ 8.2 Hz, ArH), 7.65 (d, 2H, J ¼ 8.2 Hz,
ArH), 8.54 (d, 1H, J ¼ 5.8 Hz, NH).
REFERENCES
1. Lee, C. W.; Cao, H.; Ichiyama, K.; Rana, T. M. Design and synthesis of a novel
peptidomimetic inhibitor of HIV-1 Tat-TAR interactions: Squaryldiamide as a
new potential bioisostere of unsubstituted guanidine. Bioorg. Med. Chem. Lett.
2005, 15, 4243–4246.
2. Porter, J. R.; Archibald, S. C.; Childs, K.; Critchley, D.; Head, J. S.; Linsley, J. M.;
Parton, T. A.; Robinson, M. K.; Shock, A.; Taylor, R. J.; Warrellow, G. J.;
Alexander, R. P.; Langham, B. Squaric acid derivatives as VLA-4 integrin antag-
onists. Bioorg. Med. Chem. Lett. 2002, 12, 1051–1054.
3. Cavanagh, R. L. BMY-25368. Drugs Fut. 1985, 10, 890.
4. Prous, J.; Castan˜er, J. IT-066. Drugs Fut. 1990, 15, 1181.
5. Gilbert, A. M.; Antane, M. M.; Argentieri, T. M.; Butera, J. A.; Francisco, G. D.;
Freeden, C.; Gundersen, E. G.; Graceffa, R. F.; Herbst, D.; Hirth, B. H.;
Lennox, J. R.; McFarlane, G.; Norton, N. W.; Quagliato, D.; Sheldon, J. H.;
Warga, D.; Wojdan, A.; Woods, M. Design and SAR of novel potassium
channel openers targeted for urge urinary incontinence, 2: Selective and potent
benzylamino cyclobutenediones. J. Med. Chem. 2000, 43, 1203–1214.
6. Kinney, W. A.; Abou-Gharbia, M.; Garrison, D. T.; Schmid, J.; Kowal, D. M.;
Bramlett, D. R.; Miller, T. L.; Tasse, R. P.; Zaleska, M. M.; Moyer, J. A.
Design and synthesis of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-
ethyl]phosphonic acid (EAA-090), a potent N-methyl-D-aspartate antagonist, via
the use of 3-cyclobutene-1,2-dione as an achiral alpha-amino acid bioisostere.
J. Med. Chem. 1998, 41, 236–246.
7. Onaran, M. B.; Comeau, A. B.; Seto, C. T. Squaric acid-based peptidic inhibitors
of matrix metalloprotease—1. J. Org. Chem. 2005, 70, 10792–10802.
8. Yagi, S.; Fujie, Y.; Hyodo, Y.; Nakazumi, H. Synthesis, structure, and com-
plexation properties with transition metal cations of a novel methine-bridged
bisquarylium dye. Dyes Pigm. 2002, 52, 245–252.
9. Lim, N. C.; Morton, M. D.; Jenkins, H. A.; Bru¨ckner, C. Squaric acid N-hydroxy-
lamides: Synthesis, structure, and properties of vinylogous hydroxamic acid
analogues. J. Org. Chem. 2003, 68, 9233–9241.
10. Xie, J.; Comeau, A. B.; Seto, C. T. Squaric acids: A new motif for designing
inhibitors of protein tyrosine phosphatases. Org. Lett. 2004, 6, 83–86.
11. Liu, H.; Tomooka, C. S.; Moore, H. W. An efficient general synthesis of squarate
esters. Synth. Commun. 1997, 27, 2177–2180.